Amplion, a leading precision medicine intelligence company, has released Dx:Revenue, a groundbreaking software solution that enables test providers to identify ideal pharmaceutical partnership opportunities at the right time to advance precision medicine collaboration. Dx: Revenue is an extension of Amplion's core business intelligence platform that leverages proprietary machine learning to deliver tailored insights into pharma and test developer activities. The platform draws from more than 34 million evidence sources such as clinical trials, scientific publications, conference abstracts, FDA cleared and approved tests, lab developed tests, diagnostic and drug pipelines and more in real time, producing prioritized and timely partnering opportunities that are a precise match between a test provider's capabilities and pharma's specific needs. "Precision medicine has a problem," says Chris Capdevila, CEO, Amplion. "There is an insurmountable volume of information with the potential to drive the realization of precision medicine for patients, but accessing that information strategically, effectively and quickly to make the best pharma partnering decisions is beyond human scale. Our company was founded to address this issue by providing critical evidence-based intelligence that supports the strategic decisions pharmaceutical and test developers need to make to be successful."
Scientists at the Energy Department's Argonne National Laboratory have pioneered a cutting-edge neuromorphic computer chip--modeled off the brains of bees, fruit flies and other insects--that can rapidly learn, adapt and use substantially less power than its conventional computer chip counterparts. The physicist leading an interdisciplinary team that developed the state-of-the-art design recently spoke to Nextgov about the chips' potential to advance artificial intelligence. "If we start from a biology standpoint, we use ourselves, humans, as a model for intelligent systems, of course. But there are many other branches that evolution has taken where you can sort of reach big computational power," Angel Yanguas-Gil, principal materials scientist in Argonne's Applied Materials division, said. "Insects are one of these areas."
One of the key reasons Amazon (NASDAQ:AMZN) stock is one of the most valuable on Wall Street -- with a market cap of $884 billion -- is that the company is willing to take bold initiatives. True, sometimes things fall short, as seen with the move into the smartphone business. But for the most part, CEO Jeff Bezos has been able to make the right strategic decisions and deploy resources in a disciplined way. Perhaps the best example of this is AWS (Amazon Web Services). Without this, AMZN stock would likely have a much lower valuation today.
We thank Twist Bioscience for synthesizing and cloning ChR sequences, D. Wagenaar (California Institute of Technology) and the Caltech Neurotechnology Center for building the mouse treadmill, J. Brake (California Institute of Technology) for performing spectrometer measurements, J. Bedbrook for critical reading of the manuscript and the Gradinaru and Arnold laboratories for helpful discussions. This work was funded by the Institute for Collaborative Biotechnologies grant no. W911NF-09-0001 from the US Army Research Office (F.H.A) and the National Institutes of Health (NIH) (V.G.): NIH BRAIN grant no. RF1MH117069, NIH Director's Pioneer Award grant no. DP1NS111369, NIH Director's New Innovator Award grant no.
For senior IT people, 2019 may not look to be the happiest of new years. Many experienced technologists are finding their roles outsourced, with other employers looking for only younger (read: cheaper) employees. "I had three jobs in three years," Mike, a 50-something New York-based IT specialist, told me a year ago. "They've all ended with even new hires being let go and the work outsourced. I had to go before a judge to explain my financial situation, and he said I should take a class to update my skills. As if that would fix it."
Earlier this month the thermal imagery manufacturer FLIR bought the UAV developer Aeryon Labs for $200 million, beating their previous record in publicly disclosed drone investments of $134M. This has been yet another signal that even though the drone industry suffered some hard hits in 2018, the period of consolidation, larger investments and serious R&D advances is ahead. In fact, if one were to look at merely the investment figures for 2018, it wouldn't even be that easy to tell that the drone industry struggled. Records were set, partnerships formed, and accelerators continued to support exceptional start-ups. A total of $702 million was invested into the drone industry in 2018 (up from $625M in 2017), $483 million of which was funnelled into the top 20 drone deals.
A fully autonomous ship called the "Mayflower" will make its voyage across the Atlantic Ocean next September, to mark the 400-year anniversary of the trip of the first Mayflower, which was very much not autonomous. It's a stark way to drive home just how much technology has advanced in the last four centuries, but also a key demonstration of autonomous seafaring technology, put together by marine research and exploration organization Promare and powered by IBM technology. The autonomous Mayflower will be decked out with solar panels, as well as diesel and wind turbines to provide it with its propulsion power, as it attempts the 3,220-mile journey from Plymouth in England, to Plymouth in Massachusetts in the U.S. The trip, if successful, will be among the first for full-size seafaring vessels navigating the Atlantic on their own, which Promare is hoping will open the doors to other research-focused applications of autonomous seagoing ships. To support that use case, it'll have research pods on board while it makes its trip. Three to be specific, developed by academics and researchers at the University of Plymouth, who will aim to run experiments in areas including maritime cybersecurity, sea mammal monitoring and even addressing the challenges of ocean-borne microplastics.
From Istanbul to Los Angeles, Dubai to New York and beyond, Asma Shabab--named a 2019 Woman to Watch for her thought leadership on how technology impacts humanity--is exactly that. "Here's to the rule breakers, the rebels and the transformers," Brandberries editor-in-chief Hamza Sarawy, who compiled the list, wrote. Shabab has always been a rebel, which she defines as continuously exploring how to challenge herself. At school, where she excelled in academics and extracurricular activities, she loved finding creative ways to address whatever was happening around her. Today, in her globe-circling career, she defines rule breakers as those who have the guts to question. "A rule breaker is someone who does things differently," she told Industrious from her Dubai home.